Abstract
Several models have been proposed for translocation of cell-penetrating peptides across membranes, but no general consensus on the mechanism of this process has emerged. It was hypothesized that heparan sulfate on the cell surface may play a role. We used fluorescence spectroscopy to study the effect of three soluble glycosaminoglycans—heparan sulfate, low-molecular-weight heparin, and dermatan sulfate—on the interaction of the fluorescently labeled peptide TAT−PTD with negatively charged small unilamellar vesicles. We found that the presence of glycosaminoglycans results in an order-of-magnitude increase in the apparent dissociation constant K d of the electrostatic component of the peptide/membrane interaction (from 0.13 to 2.6 mM). Thus, rather than aiding in the peptide’s penetration, soluble glycosaminoglycans competitively decrease TAT−PTD’s binding to the membrane, presumably by neutralizing its charge, and thereby attenuating electrostatic forces involved in the interaction. Our results, however, do not exclude a possible role of membrane-anchored glycosaminoglycans in the endocytotic transduction of CPPs across the cell membrane.
Similar content being viewed by others
References
Aris A, Villaverde A (2003) Engineering nuclear localization signals in modular protein vehicles for gene therapy. Biochem Biophys Res Commun 304:625–631
Barany-Wallje E, Keller S, Serowy S, Geibel S, Pohl P, Bienert M, Dathe M (2005) A critical reassessment of penetratin translocation across lipid membranes. Biophys J 89:2513–2521
Belting M (2003) Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem Sci 28:145–151
Bielinska A, Kukowska-Latallo JF, Johnson J, Tomalia DA, Baker JR Jr (1996) Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res 24:2176–2182
Butko P, Huang F, Pusztai-Carey M, Surewicz WK (1996) Membrane permeabilization induced by cytolytic delta-endotoxin CytA from Bacillus thuringiensis var. israelensis. Biochemistry 35:11355–11360
Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 271:18188–18193
Derossi D, Joliot AH, Chassaing G, Prochiantz A (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269:10444–10450
Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435–471
Frankel AD, Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189–1193
Hitz T, Iten R, Gardiner J, Namoto K, Walde P, Seebach D (2006) Interaction of alpha and beta-oligoarginine-acids and amides with anionic lipid vesicles: a mechanistic and thermodynamic study. Biochemistry 45:5817–5829
Kaplan IM, Wadia JS, Dowdy SF (2005) Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 102:247–253
Klein D, Mendoza V, Pileggi A, Molano RD, Barbe-Tuana FM, Inverardi L, Ricordi C, Pastori RL (2005) Delivery of TAT/PTD-fused proteins/peptides to islets via pancreatic duct. Cell Transplant 14:241–248
Kramer SD, Wunderli-Allenspach H (2003) No entry for TAT(44–57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides. Biochim Biophys Acta 1609:161–169
Kukowska-Latallo JF, Raczka E, Quintana A, Chen C, Rymaszewski M, Baker JR Jr (2000) Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Hum Gene Ther 11:1385–1395
Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410–414
Lundberg M, Johansson M (2002) Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem Biophys Res Commun 291:367–371
Oehlke J, Scheller A, Wiesner B, Krause E, Beyermann M, Klauschenz E, Melzig M, Bienert M (1998) Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim Biophys Acta 1414:127–139
Ozaki D, Sudo K, Asoh S, Yamagata K, Ito H, Ohta S (2004) Transduction of anti-apoptotic proteins into chondrocytes in cartilage slice culture. Biochem Biophys Res Commun 313:522–527
Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B, Chernomordik LV (2005) Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 280:15300–15306
Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, Chernomordik LV, Lebleu B (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278:585–590
Sandgren S, Cheng F, Belting M (2002) Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J Biol Chem 277:38877–38883
Silhol M, Tyagi M, Giacca M, Lebleu B, Vives E (2002) Different mechanisms for cellular internalization of the HIV–1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 269:494–501
Thoren PE, Persson D, Isakson P, Goksor M, Onfelt A, Norden B (2003) Uptake of analogs of penetratin, Tat(48–60) and oligoarginine in live cells. Biochem Biophys Res Commun 307:100–107
Tiriveedhi V, Butko P (2007) A fluorescence spectroscopy study on the interactions of the TAT−PTD peptide with model lipid membranes. Biochemistry 46:3888–3895
Torchilin VP, Rammohan R, Weissig V, Levchenko TS (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 98:8786–8791
Tyagi M, Rusnati M, Presta M, Giacca M (2001) Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276:3254–3261
Vives E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272:16010–16017
Vives E, Richard JP, Rispal C, Lebleu B (2003) TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci 4:125–132
Zhuo RX, Du B, Lu ZR (1999) In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J Control Release 57:249–257
Ziady AG, Ferkol T, Gerken T, Dawson DV, Perlmutter DH, Davis PB (1998) Ligand substitution of receptor targeted DNA complexes affects gene transfer into hepatoma cells. Gene Ther 5:1685–1697
Ziegler A, Blatter XL, Seelig A, Seelig J (2003) Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis. Biochemistry 42:9185–9194
Ziegler A, Seelig J (2004) Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys J 86:254–263
Ziegler A, Seelig J (2008) Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds. Biophys J 94:2142–2149
Zorko M, Langel U (2005) Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 57:529–545
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tiriveedhi, V., Butko, P. Soluble Glycosaminoglycans Inhibit the Interaction of TAT−PTD with Lipid Vesicles. Int J Pept Res Ther 14, 209–214 (2008). https://doi.org/10.1007/s10989-008-9131-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-008-9131-6